S&C represented Piper Jaffray in its $485 million acquisition of Sandler O’Neill, which took home the top prize as “Deal of the Year” at
The Deal’s Middle Market Awards. S&C also advised on another winning deal, Merck’s $300 million acquisition of late-stage immunotherapy company Immune Design, which was awarded “Healthcare, Pharma & Biotech Deal of the Year.” S&C represented Lazard, financial adviser to Immune Design.
The Deal Middle Market awards recognize the leading lawyers, bankers, investors and advisers in middle-market transactions.
Our
global M&A practice advises companies on a range of strategic transactions, including middle market deals. Learn more about our multidisciplinary approach to mergers, acquisitions, dispositions of, and investments in, the full range of financial services companies
here and our unparalleled experience advising M&A financial advisers in a diverse array of transactions
here.